The Minister of Health and Social Protection, Khalid Ait Taleb, stressed the need to encourage the national pharmaceutical industry to facilitate citizens’ access to drugs and treatments, by trusting Moroccan scientific skills and encouraging “made in Morocco” solutions.
This Tuesday, November 23 during the presentation and discussion of the sub-budget of the Ministry of Health and Social Protection within the Education, Cultural and Social Affairs Commission of the Chamber of Councilors, Khaled Ait Taleb stressed that the royal vision to achieve vaccine sovereignty is the appropriate response to the risks of emergence of new viral mutants.
The Minister underlines the importance of a “new development model”, which guarantees all Moroccan citizens equity access to quality medicines and health products, as well as to support the local manufacture of medicines in within the framework of existing partnerships between the public and private sectors.
Ait Taleb revealed that the pharmaceutical industry in Morocco has recorded significant achievements, allowing it to cover more than 70% of the local market needs for drugs thanks to the Moroccan industry and encouraging the local manufacture of expensive drugs and against diseases. chronic.
The Minister of Health and Social Protection indicated that the policy of lowering drug prices continued by lowering the prices of around 1,600 additional drugs during the period 2019-2021, the most widely consumed in the country. Morocco for the treatment of certain serious and chronic diseases, recording an improvement in the use of generic drugs to 40% currently.
.
